Skip to main content
Clinical Trials/NCT00265408
NCT00265408WithdrawnPhase 1

Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection

University of California, San Diego1 site in 1 countryStarted: December 2005Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 1
Status
Withdrawn
Locations
1
Primary Endpoint
Incidence of stroke by one year.

Study Overview

Brief Summary

Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection.

Detailed Description

20 patients with cervicocephalic arterial dissection will be randomized to open-label aspirin or warfarin, rate of stroke and adverse events will be endpoints.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Clinical and imaging diagnosis of cervicocephalic arterial dissection within 3 months.

Exclusion Criteria

  • Any contraindication to aspirin or warfarin.

Arms & Interventions

aspirin

Experimental

Intervention: aspirin (Drug)

warfarin

Experimental

Intervention: warfarin (Drug)

Outcomes

Primary Outcomes

Incidence of stroke by one year.

Time Frame: 1 year

Secondary Outcomes

  • Recurrent dissection by one year.(1 year)
  • Incidence of TIA by one year.(1 year)
  • Incidence of major and minor bleeding episodes by one year.(1 year)

Investigators

Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials

Pilot Study of Aspirin Versus Warfarin for... | Clinical Trial